» Articles » PMID: 26084609

MiR-570 Inhibited the Cell Proliferation and Invasion Through Directly Targeting B7-H1 in Hepatocellular Carcinoma

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2015 Jun 19
PMID 26084609
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

A recent study reported that miR-570 was the most important microRNA in the microRNA gene networks of alcoholic liver disease that has the potential of progressing to hepatocellular carcinoma. However, litter is known regarding the expression and specific function of miR-570 in the progression of hepatocellular carcinoma, especially its molecular mechanisms by which miR-570 exerts its functions and modulates the malignant phenotypes of hepatocellular carcinoma cells. Here, we observed that miR-570 was highly expressed in hepatocellular carcinoma cell lines (Bel-7404, Huh-7, and HepG2), while B7-H1 was lowly expressed, compared to nonmalignant cell line (L-02 and HL-7702). Transfection of miR-570 mimics or knockdown of B-H1 suppressed the expression of B7-H1, which promotes cell apoptosis and inhibits the cell proliferation and invasion. Using a dual-luciferase reporter system, we verified that B7-H1 is a direct target of miR-570. The overexpression of B7-H1 reversed the inhibition of proliferation and invasion by miR-570. In addition, miR-570 suppressed tumorigenicity in vivo. Hence, our observation confirmed that miR-570 works as proliferation and metastatic suppressor in hepatocellular carcinoma cells through directly targeting B7-H1 in hepatocellular carcinoma cell and rationally presents that miR-570 has the potential to be a useful clinical noninvasive diagnostics or predictive marker in human hepatocellular carcinoma.

Citing Articles

Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs.

Waryah C, Alves E, Mazzieri R, Dolcetti R, Thompson E, Redfern A Cancers (Basel). 2023; 15(12).

PMID: 37370762 PMC: 10326823. DOI: 10.3390/cancers15123152.


Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition.

Tao S, Liang S, Zeng T, Yin D Front Immunol. 2023; 13:1043667.

PMID: 36685594 PMC: 9845774. DOI: 10.3389/fimmu.2022.1043667.


The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer.

Kipkeeva F, Muzaffarova T, Korotaeva A, Mansorunov D, Apanovich P, Nikulin M Int J Mol Sci. 2022; 23(16).

PMID: 36012588 PMC: 9409052. DOI: 10.3390/ijms23169324.


MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma.

Gramantieri L, Fornari F, Giovannini C, Trere D Biomolecules. 2022; 12(7).

PMID: 35883486 PMC: 9313100. DOI: 10.3390/biom12070930.


Epigenetic mechanisms of liver tumor resistance to immunotherapy.

Sanceau J, Gougelet A World J Hepatol. 2021; 13(9):979-1002.

PMID: 34630870 PMC: 8473495. DOI: 10.4254/wjh.v13.i9.979.


References
1.
Chan B, Manley J, Lee J, Singh S . The emerging roles of microRNAs in cancer metabolism. Cancer Lett. 2014; 356(2 Pt A):301–8. DOI: 10.1016/j.canlet.2014.10.011. View

2.
Zhang X, Chang Q, Zeng L, Gu J, Brown S, Basch R . TBLR1 regulates the expression of nuclear hormone receptor co-repressors. BMC Cell Biol. 2006; 7:31. PMC: 1555579. DOI: 10.1186/1471-2121-7-31. View

3.
Wu C, Zhu Y, Jiang J, Zhao J, Zhang X, Xu N . Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance. Acta Histochem. 2006; 108(1):19-24. DOI: 10.1016/j.acthis.2006.01.003. View

4.
Yoon H, Chan D, Huang Z, Li J, Fondell J, Qin J . Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 2003; 22(6):1336-46. PMC: 151047. DOI: 10.1093/emboj/cdg120. View

5.
Lewis B, Burge C, Bartel D . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. DOI: 10.1016/j.cell.2004.12.035. View